Home
Conditions
Pancreatic Ductal Adenocarcinoma

Clinical trial condition

Pancreatic Ductal Adenocarcinoma

Explore clinical trials studying Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.

181 public trials 74 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Ductal Adenocarcinoma trial results

Recruiting

Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer

NCT06600906

Conditions: Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Recruiting

Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma

NCT07096362

Conditions: Metastatic Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma
Locations: University of Miami Miami, Florida, United States

View Trial Details

Recruiting

Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas

NCT07155525

Conditions: Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +26 more
Locations: Liver and GIT hospital , Minia University Minya, Minya Governorate, Egypt

View Trial Details

Recruiting

UCSF PANC Cyst Registry

NCT04291651

Conditions: Adenoma, Cystadenoma, Cystadenoma, Serous, +21 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Recruiting

Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma

NCT06831136

Conditions: Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +3 more
Locations: The University of Texas Health Science Center at Houston Houston, Texas, United States

View Trial Details

Recruiting

Mesopancreatic Excision for Pancreatic Duct Adenocarcinoma.

NCT07148830

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations: Liver and GIT hospital , Minia University Minya, Minya Governorate, Egypt

View Trial Details

Recruiting

Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer

NCT05132504

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Baylor College of Medicine Houston, Texas, United States

Baylor St. Luke's Medical Center (BSLMC). Houston, Texas, United States

Houston Methodist Hospital Houston, Texas, United States

View Trial Details

Recruiting

French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

NCT06287749

Conditions: CtDNA, Liquid Biopsy, Minimal Residual Disease, +7 more
Locations: CHU de Montpellier Montpellier, Hérault, France

View Trial Details

Recruiting

AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort

NCT06638866

Conditions: Digestive System Diseases, Digestive System Neoplasms, Disease, +13 more
Locations: Shanghai Changhai Hospital Shanghai, Shanghai Municipality, China

Second Affiliated Hospital of Jiaxing University Jiaxing, Zhejiang, China

Yinzhou Hospital Affiliated to Medical School of Ningbo University Ningbo, Zhejiang, China

View Trial Details

Recruiting

Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types

NCT06782412

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +14 more
Locations: University Hospital Antwerp (UZA) Edegem, Belgium

University Hospital Ghent Ghent, Belgium

UZ Leuven Leuven, Belgium

View Trial Details

Pancreatic Ductal Adenocarcinoma

Pancreatic Ductal Adenocarcinoma trial results

Related conditions